KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Pension (2018 - 2025)

Takeda Pharmaceutical (TAK) has 8 years of Pension data on record, last reported at $887.7 million in Q1 2025.

  • For Q1 2025, Pension fell 8.57% year-over-year to $887.7 million; the TTM value through Mar 2025 reached $887.7 million, down 8.57%, while the annual FY2025 figure was $889.1 million, 10.89% down from the prior year.
  • Pension reached $887.7 million in Q1 2025 per TAK's latest filing, down from $970.9 million in the prior quarter.
  • Across five years, Pension topped out at $1.5 billion in Q1 2021 and bottomed at $887.7 million in Q1 2025.
  • Average Pension over 5 years is $1.1 billion, with a median of $970.9 million recorded in 2024.
  • Peak YoY movement for Pension: grew 4.34% in 2021, then fell 23.14% in 2023.
  • A 5-year view of Pension shows it stood at $1.5 billion in 2021, then dropped by 16.38% to $1.3 billion in 2022, then dropped by 23.14% to $964.6 million in 2023, then increased by 0.65% to $970.9 million in 2024, then fell by 8.57% to $887.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Pension were $887.7 million in Q1 2025, $970.9 million in Q1 2024, and $964.6 million in Q1 2023.